Quantcast

Latest glioblastoma multiforme Stories

2014-06-17 08:28:31

Companies expect to commence first-in-human studies of Trx-1 in ovarian cancer in 1H15 BOSTON, June 17, 2014 /PRNewswire/ -- Australian oncology drug development company Novogen Limited [ASX:NRT; NASDAQ:NVGN] and CanTx Inc., its joint venture with Yale University, today announced the success of proof-of-concept pre-clinical studies confirming the potency of experimental drug, Trx-1, in the treatment of primary ovarian cancer when delivered into the peritoneal cavity. Based on the...

2014-06-15 14:59:20

Broad Institute of MIT and Harvard Cellular makeup of glioblastoma more diverse than previously thought Scientists from the Broad Institute and Massachusetts General Hospital (MGH) have conducted a first-of-its-kind study that characterizes the cellular diversity within glioblastoma tumors from patients. The study, which looked at the expression of thousands of genes in individual cells from patient tumors, revealed that the cellular makeup of each tumor is more heterogeneous than...

2014-06-13 08:23:58

Analysis of PRiDe, a U.S. commercial registry of 457 recurrent glioblastoma patients, demonstrates that patients treated with NovoTTF Therapy at their first recurrence achieved a median overall survival of 20 months NEW YORK, June 13, 2014 /PRNewswire/ -- Novocure, a commercial stage oncology company, announced today that subgroup survival data from its U.S. commercial patient registry will be presented at the 16(th) Biennial Canadian Neuro-Oncology Meeting in Halifax, Nova Scotia,...

2014-06-11 08:29:54

All 9 Out Of 9 Patients Who Have Reached 4 Injections Are Showing Tumor Cell Death, Tumor Shrinkage And/Or Stabilization Of Disease BETHESDA, Md., June 11, 2014 /PRNewswire/ -- Northwest Biotherapeutics (NASDAQ: NWBO) (NW Bio), a biotechnology company developing DCVax® personalized immune therapies for solid tumor cancers, announced today that, in the ongoing Phase I/II clinical trial of DCVax-Direct for all types of inoperable solid tumors, all 9 out of 9 patients who have...

2014-06-10 12:31:14

LONDON, June 10, 2014 /PRNewswire/ -- Reportbuyer.com has added a new market research report:Recurrent Malignant Glioma - Pipeline Review, H1 2014http://www.reportbuyer.com/pharma_healthcare/diseases/recurrent_malignant_glioma_pipeline_review_h1_2013.html Recurrent Malignant Glioma - Pipeline Review, H1 2014SummaryGlobal Markets Direct's, 'Recurrent Malignant Glioma - Pipeline Review, H1 2014', provides an overview of the Recurrent Malignant Glioma's therapeutic pipeline.This report...

2014-06-04 12:29:56

BETHESDA, Md., June 4, 2014 /PRNewswire/ -- Northwest Biotherapeutics, Inc. (NASDAQ: NWBO) ("NW Bio"), a biotechnology company developing DCVax® personalized immune therapies for cancer, announced today that Linda F. Powers, CEO, will present at the Jefferies 2014 Global Healthcare Conference, which is being held in New York. http://photos.prnewswire.com/prnvar/20110329/SF73084LOGO NW Bio's presentation will take place on Wednesday, June 4, at 2:00 p.m. EDT in Ballroom 5 at the...

2014-06-03 23:08:44

ResearchMoz.us include new market research report "Breast Cancer Therapeutics in Major Developed Markets to 2020 - Approval of Novel Therapies to Support Continued Dominance of HER2 Targeted Drugs" to its huge collection of research reports. Albany, NY (PRWEB) June 03, 2014 "Breast Cancer Therapeutics in Major Developed Markets to 2020 – Approval of Novel Therapies to Support Continued Dominance of HER2 Targeted Drugs", which provides in-depth analysis of breast...

2014-06-03 23:06:52

ResearchMoz includes new market research report "AntiHypertensive Market and Glioblastoma Multiforme (GBM) Markets to 2019" to its huge collection of research reports. View all reports in Therapeutic Area Market Research at http://www.researchmoz.us/therapeutic-area-market-reports-37.html. Albany, NY (PRWEB) June 03, 2014 Anti-Hypertensive Therapeutics in Major Developed Markets to 2020 – Increased Uptake of Combination Therapies to Offset Effects of Key Patent Expiries...

2014-06-02 16:27:33

Company invites individual and institutional investors as well as advisors to attend interactive real-time virtual RetailInvestorConferences.com VANCOUVER, British Columbia and MENLO PARK, Calif., June 2, 2014 /PRNewswire/ -- DelMar Pharmaceuticals, Inc. (OTCQB: DMPI) ("DelMar" and "DelMar Pharma"), a clinical-stage company advancing breakthrough cancer therapeutics and located in Vancouver, British Columbia and Menlo Park, Calif., today announced that Jeffrey Bacha, B.Sc., MBA, president...

2014-06-01 08:20:27

Pre-specified MGMT and HLA Subgroup Analyses Show Potentially Clinically Meaningful Survival Advantages for ICT-107 Treated Patients LOS ANGELES, June 1, 2014 /PRNewswire/ -- ImmunoCellular Therapeutics, Ltd. ("ImmunoCellular") (NYSE MKT:IMUC) announced that updated efficacy and safety data from the phase II trial of dendritic cell-based immunotherapeutic vaccine ICT-107 in patients with newly diagnosed glioblastoma multiforme (GBM) were presented at the 2014 American Society for Clinical...


Word of the Day
mallemaroking
  • Nautical, the visiting and carousing of sailors in the Greenland ships.
This word is apparently from a confusion of two similar Dutch words: 'mallemerok,' a foolish woman, and 'mallemok,' a name for some persons among the crew of a whaling vessel.